[1]
“Repurposing Kinase Inhibitors for COVID-19 A Comprehensive Review of Antiviral and Immunomodulatory Effects”, IJPHI, vol. 1, no. 03, pp. 217–226, Jun. 2024, doi: 10.62752/.